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Renal transport of oxalate: Effects of diuretics, uric acid, and
calcium. Clearance experiments were performed in the rat to ex-
amine the effects of diuretics on the renal transport of oxalate. In
addition, the effect of infusing either uric acid or calcium on the
renal transport of oxalate was examined. During control periods,
the fractional excretion of oxalate (FE0,,) averaged 118.0 2.1%.
Acute administration of either chiorothiazide, furosemide, or in-
danyl-oxyacetic acid (MK-196), a new uricosuric diuretic, result-
ed in a significant decrease in the FE0,, in all groups to 104.8
2.4%, 111.3 2.1%, and 108.6 2.7%, respectively. Infusion of
uric acid increased urinary uric acid excretion from 2.41 0.28
to 4.26 0.03 ig/min/g kidney wt (P < 0.001) and decreased
FE0,, to 104.0 2.4% (P <0.001 compared to control). Infusion
of calcium chloride increased urinary calcium excretion from
0.10 0.04 to 0.44 0.06 gJmin/g kidney wt (P < 0.001) but
hadnoeffectontheFE0whichaveraged 118.3 8.3%(P = NS
compared to control). These studies show that the acute adminis-
tration of chlorothiazide, furosemide, or MK-196, as well as in-
creasing urinary uric acid excretion by uric acid infusion, are all
associated with a decrease in the FE0,,. Acutely increasing uri-
nary calcium excretion, however, had no effect on oxalate trans-
port.
Transport renal de l'oxalate: Effets des diuretiques, de l'acide
urique, et du calcium. Des experiences de clearance ont été réa-
lisées chez le rat pour étudier les effets des diurCtiques sur le
transport renal de l'oxalate. De plus, I'effet de l'administration
d'acide urique ou de calcium sur le transport renal de l'oxalate a
été étudié. Au cours des périodes témoins, l'excrétion fraction-
nelle de l'oxalate (FE0,,) est en moyenne de 118,0 2,1%.
L'administration de chlorothiazide, de furosémide ou d'acide in-
danyl-oxyacétique (MK-196), un nouveau diurétique un-
cosurique, determine une diminution significative de FE0, dans
tousles groupes, a 104,8 2,4%, 111,3 2,1%, et 108,6 2,7%,
respectivement. L'administration d'acide unique augmente
l'excrétion urinaire d'acide urique de 2,41 0,28 a 4,26 0,03
j.gImin/g de rein (P < 0,001) et diminue FE0,, a 104,0 2,4% (P
< 0,001 par comparison aux contrôles). L'administration de
chiorure de calcium augmente l'excrétion urinaire de calcium de
0,10 0,04 a 0,44 0,06 g/min/g de rein (P <0,001) mais n'a
pas d'effet sur FE0,, qui est en moyenne de 118,3 8,3% (P =
NS par comparison aux contrôles). Ces résultats montrent que
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l'administration aiguë de chlorothiazide, de furosémide ou de
MK-196, de méme que l'augmentation de l'excrétion urinaire
d'acide unique par la perfusion d'acide unque sont associées a
une diminution de FE0,,. L'augmentation de l'excrétion urinaire
de calcium n'a, cependant, pas d'effet sur Ic transport d'oxalate.
Diuretics are commonly used in the management
of patients with recurrent calcium oxalate nephro-
lithiasis [1, 2]. Their effects on calcium and uric acid
excretion by the kidney have been extensively stud-
ied [3-7]. Little is known, however, about the ef-
fects of these agents on the renal handling of oxa-
late. In addition, the relationships between the uri-
nary excretion of calcium and oxalate and the
urinary excretion of uric acid and oxalate have not
been well established. The purpose of the present
studies was, therefore, to examine the effects of
three different diuretic agents on the renal handling
of oxalate. The diuretics studied were chiorothia-
zide, furosemide, and indanyl-oxyacetic acid (MK-
196), a new diuretic agent which possesses marked
uricosuric properties [8, 9]. The effect of increasing
the renal excretion of calcium or uric acid on oxa-
late transport was also examined.
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Methods
Male Sprague-Dawley rats weighing between 250
and 400 g were used in all studies. Animals were
anesthetized with pentobarbital sodium (50 to 60
mg/kg) administered intraperitoneally. After a tra-
cheostomy, both jugular veins were cannulated,
and the urinary bladder was catheterized. Body
temperature was maintained constant at 37 to 38° C
by the use of an animal-heating board. Surgical fluid
losses were replaced with a volume of isotonic sa-
line solution equal to 1% of body weight. A 1 .2-ml
priming dose of an isotonic saline solution contain-
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ing 25 sCi/mi of [inethoxy-3H]-inuiin (New England
Nuclear, Boston, Massachusetts) and 25 sCi/mi of
uniformly labeled [14C]-oxalic acid (Amersham
Searie, Arlington Heights, Illinois) was given, fol-
lowed by a sustaining infusion of the same solution
at a rate of 1.2 mi/hr. After 90 mm of equilibration
time, two or three 30-mm urine collections were ob-
tained. Blood was collected from the tail vein at the
midpoint of each clearance period. During the con-
trol periods, the animals also received an additional
infusion of isotonic saline at a rate of 1.2 mi/hr to
control for the volume of the diluent solutions used
in the various experimental protocols.
After collection of blood and urine samples dur-
ing the control periods, five different experimental
protocols were followed. Six rats received a bolus
intravenous infusion of chiorothiazide (15 mg/kg
body wt) followed by a sustaining infusion of
chlorothiazide at 15 mg/kg body wt/per hour
(group I). Six animals received a bolus infusion of
furosemide (15 mg/kg body wt) followed by a sus-
taining infusion of furosemide at 15 mg/kg body wt/
per hour (group II). Six animals (group III) re-
ceived an intravenous bolus infusion of MK-196 (50
mg/kg body wt) followed by a sustaining infusion of
MK-196 at a rate of 50 mg/kg body wt per hour. In
five animals (group IV), a 0.l-g/lOO ml solution of
uric acid in normal saline was infused at a rate of 1.2
mi/hr. In group V (five animals), a solution of cal-
cium chloride (800 mgIlOO ml) was infused at a rate
of 1.0 mi/hr.
In all experimental groups of animals, a 90-mm
equilibration period was allowed to elapse after ad-
ministration of the experimental agent. So as to pre-
vent changes in the extracellular fluid volume, we
replaced urinary losses of sodium and water with an
equal volume of isotonic saline. After the equilibra-
tion period, two or three 30-mm urine collections
were again obtained along with midpoint tail vein
blood collections. Four additional animals were
studied to determine if, during the time course of
these experiments, oxalate excretion was changing.
In these studies, after collection of samples during
the control periods, the animals received a bolus in-
fusion of 1 ml of isotonic saline. After an additional
waiting period of 90 mm, blood and urine samples
were collected. At the end of each experiment, both
kidneys were removed and stripped of perirenal fat
and capsule and weighed on an analytic scale.
Radioactivity of blood and urine was determined
in Biofluor (New England Nuclear, Boston, Massa-
chusetts) in a Tri-carb liquid scintillation counter
(Packard Instruments Co., Downers Grove, Illi-
nois). Counts per minute were converted to dis-
integrations per minute after correction for quench,
crossover counts, and efficiency of counting. Uri-
nary uric acid concentration was measured by a
specific uricase method utilizing the oxygen sensor
in a Beckman glucose analyzer (Beckman In-
struments Co., Palo Alto, California). Serum was
ultracentrifuged using Amicon ultrafiltration cones
(Amicon Corp., Lexington, Massachusetts) for de-
termination of ultrafilterable calcium concentra-
tions. Serum ultrafilterable calcium and urinary cal-
cium concentrations were measured by atomic ab-
sorption spectrophotometry. Hematocrits were
measured in heparinized microhematocrit tubes.
Glomerular filtration rate (GFR) and clearance of
oxalate (C0) were determined from standard for-
mulae and expressed as microliters per minute per
gram of kidney weight. Fractional excretion of oxa-
late (FE0) was determined according to the follow-
ing calculation:
FE0 (%) = (C0X/C1) X 100
where C0, is the clearance of [14C]-oxalate and C1 is
the clearance of [methoxy-3H]-inulin. For each ani-
mal, control or experimental observations were av-
eraged and the results expressed as the mean of
means SEM. Although experiments were per-
formed in a paired manner, the results of control
values in all groups were similar. Thus, control val-
ues were pooled and, for clarity of presentation,
data were analyzed statistically using the t test for
unpaired data. When analyzed as paired observa-
tions, the conclusions derived were not different
than those observed using the t test for unpaired
data.
Results
Results are presented in Table 1. There were no
differences in any of the measured parameters dur-
ing the control periods in any of the various groups
of animals studied. For purposes of data presenta-
tion, therefore, all the control periods have been av-
eraged together. During the control period, GFR
averaged 1190 61 dImin/g kidney wt, and the FE0
averaged 118.0 2.1%. In the group-I animals, fol-
lowing the infusion of chiorothiazide, the GFR de-
creased to 1032 41 il/min/g kidney wt (P <0.05,
compared to control). As compared to controls,
there was a significant decrease in the FE0 to 104.8
2.4% (P <0.001). Urinary sodium excretion in-
creased from 0.08 0.01 to 4.03 2.0 Eq/min/g
kidney wt. Following the administration of furose-
mide (group II), the GFR was less than control and
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averaged 866 43 pilminig kidney wt, whereas the
FE0 decreased to 111.3 2.1 (P <0.001 and 0.02,
respectively, compared to control values). UNaV
was 6.70 0.70 EqIminIg kidney wt. In group III,
following the infusion of MK-l96, GFR was signifi-
cantly decreased to 838 34 pilminlg kidney wt (P
<0.001, compared to control). The FE0 was also
significantly decreased to 108.6 2.7% (P <0.01).
UNaV was 10.03 2.79 Eq/min/g kidney wt. Thus,
all three diuretic agents examined significantly de-
creased the fractional excretion of ['4C]-oxalate.
The intravenous infusion of uric acid (group IV)
resulted in a significant increase in the urinary ex-
cretion of uric acid from 2.41 0.28 in controls to
4.26 0.03 g/min/g kidney wt (P < 0.001). The
FE0 in this group averaged 104.0 2.4% (P <
0.001, compared to controls). Following the admin-
istration of calcium chloride (group V), there was a
significant increase in ultrafilterable calcium con-
centration from 3.7 to 6.5 mg/lOO ml. Associated
with this increase in serum ultrafilterable calcium
was a significant increase in the urinary excretion of
calcium from 0.10 0.04 to 0.44 0.06 /Lg!min/g
kidney wt (P <0.001). The infusion of calcium chlo-
ride, however, did not alter the FE0, which aver-
aged 118.3 8.3% (P = NS, compared to control).
In animals serving as time controls, the GFR av-
eraged 815.0 55.4 pi/min/g kidney wt and 768.0
47.2, and the FE0averaged 118.9 3.1% and 119.7
2.1% in control and experimental periods, re-
spectively (P = NS).
Because it was possible that the diuretics used or
the infusion of urate or calcium could affect the en-
dogenous production rate of oxalate, ten additional
animals were studied as indicated, except that the
clearance periods were extended to allow the col-
lection of 3 to 4 ml of urine. After collection of con-
trol samples, chlorothiazide, furosemide, MK-196,
uric acid, or calcium was infused as described (two
animals in each experimental group). Urinary oxa-
late concentration was determined by the method of
Hodgkinson and Williams [10], and the urinary spe-
cific activity was calculated. In the control periods,
the specific activities averaged 43.4 x 10 dpm/nmole
of oxalate. In the experimental periods, the specific
activities averaged 40.8 x l0 (range, 34.5 x 10 to
46.6 x l0), with no distinct differences in any of the
subgroups. These findings would suggest that the
experimental maneuvers themselves did not affect
endogenous oxalate production and that the isotope
clearances reflect alterations in the renal tubular
transport of oxalate. This conclusion, however,
must be tempered by the fact that the number of
specific activity determinations in any subgroup is
small, that little is known about possible factors in-
fluencing the chemical determination of oxalate in
rat urine, and that the determination of urinary oxa-
late, by any of the currently available methods, is
less than optimal.
Discussion
The effects of diuretics on the renal handling of
calcium and urate have been studied extensively [3-
7]. The effect of these agents on the renal transport
of oxalate, another important constituent of renal
stones, on the other hand, has received only limited
attention. The current studies indicate that chloro-
thiazide, furosemide, and MK-196 alter the renal
handling of oxalate and result in a significant de-
crease in its fractional rate of excretion. Prior stud-
ies from this laboratory have demonstrated that
oxalate is freely filtered at the glomerulus and un-
dergoes net secretion in the proximal portion of the
nephron. In this same nephron segment, an absorp-
tive flux can also be demonstrated. There does not,
however, appear to be any significant oxalate trans-
port in nephron segments beyond the proximal con-
voluted tubule [11]. Chlorothiazide has as its major
site of action the distal convoluted tubule, although,
under some circumstances, an inhibition of proxi-
mal reabsorption of sodium can also be demon-
strated [6, 12]. This latter effect may be related to its
carbonic anhydrase inhibitory activity. It seems un-
Table 1. Effect of diuretics, uric acid, and cal cium on oxalate excretiona
GFR Co,
pilminig kidney WI pilminig kidney wt
FEo
%
UNaV
pEq/,nin/g kidney wi
Hct
vol %
Control
Group I(chlorothiazide)
Group II (furosemide)
Group III (MK-196)
Group IV (uric acid)
Group V(calcium)
1190 61 1396 63
1032 41 1072 63
866 43 962 43
838 34 910 42
1371 74 1372 73
1330 110 1600 225
118.0
104.8
111.3
108.6
104.0
118.3
2.1
2.4
2.1
2.7
2.4
8.3
0.08 0.01
4.03 2.20
6.70 0.70
10.03 2.79
2.47 0.94
0.13 0.06
50 1
53 1
50 I
48 1
47 I
49 1
a Values are mean ScM. See Results section for statistics.
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likely that chlorothiazide would decrease the frac-
tional excretion of oxalate by enhancing its reab-
sorption, because prior studies have indicated that
oxalate transport is independent of the rate of so-
dium reabsorption, the pH of the urine, or the state
of hydration of the extracellular fluid volume [13].
Because chiorothiazide is an organic acid, it is possi-
ble that it competes with oxalate for a common
organic acid secretory site. Furosemide and MK- 196
do not significantly alter proximal sodium reabsorp-
tion [9, 14]. Because both of these agents are also
organic acid compounds, they too, like chlorothi-
azide, may inhibit the tubular secretion of oxalate
and thus decrease its fractional excretion. Cohanim
and Yendt have reported previously that the chronic
administration of a thiazide diuretic to patients with
recurrent calcium oxalate stones was associated
with a decrease in oxalate excretion [15]. Because
only the urinary excretion rate was determined, it
is unclear from these studies whether thiazides al-
tered renal oxalate transport or whether the de-
creased rate of oxalate excretion was a secondary
consequence of decreased oxalate absorption from
the gastrointestinal tract, as postulated by Yendt
[16]. We are unaware of any other studies directly
examining this question. The present results would
indicate, however, that at least in the rat, acute
administration of the diuretic agents alters the
tubular handling of oxalate.
The effects of infusing exogenous uric acid on
oxalate transport were undertaken to explore the
relationship between the renal handling of these two
endogenous organic acids. As noted in Table 1,
urate infusion significantly decreased the fractional
excretion of oxalate. As with the diuretics, the pre-
cise mechanism is unknown, but the results of these
experiments are of interest. The nephron site of
urate secretion is not known with certainty, but de
Rougemont, Henchoz, and Roch-Ramel [17] and
Roch-Ramel et a! [18] have advanced evidence for a
secretory site for urate located in the immediate
postglomerular portion of the superficial proximal
tubule of the rat, as well as in the remainder of the
proximal convoluted tubule available for micro-
puncture. Our prior micropuncture studies have
indicated that these same nephron segments are
responsible for oxalate secretion [11]. Moreover,
recent studies from this laboratory have demon-
strated that infusion of the organic acid para-amino-
hippurate inhibits the tubular secretion of oxalate
[13]. It is tempting to speculate, therefore, that
urate and oxalate may share a common secretory
mechanism.
In contrast to the administration of the organic
acid compounds, the infusion of calcium did not
affect the fractional excretion of oxalate. These
results are in contrast to the effects of calcium ad-
ministration on the transport of oxalate in the gas-
trointestinal tract where an increase in calcium con-
centration results in decreased oxalate absorption
[19]. In the sheep, calcium infusions for 5 days have
been reported to result in a significant increase in
oxalate excretion [20]. The difference between
those results and those of the present study may be
due to species differences or to the duration or
amount of calcium infused. In the rat at least, acute
alterations in the rate of calcium excretion in the
urine do not appear to have a regulatory role in oxa-
late excretion by the kidney.
It should be emphasized that the present studies
examined only the acute effects of the diuretics,
uric acid, and calcium on the renal transport of oxa-
late. A prolonged decrease in the renal excretion of
oxalate would tend to elevate plasma oxalate con-
centration and thus increase the filtered load. Under
chronic conditions, this increase in the filtered load
of oxalate may offset the change in transport ob-
served in these acute studies. Long-term studies
would be needed to directly examine this possi-
bility.
In summary, these clearance studies in the rat
demonstrate that the acute administration of chloro-
thiazide, furosemide, or MK-l96 is associated with
a decrease in the fractional excretion of oxalate.
The doses of diuretics used in these studies are mas-
sive when compared to doses used in man, and thus
caution must be used in extrapolating the results of
these studies to observations regarding oxalate ex-
cretion in man following diuretic administration. In
addition, the infusion of uric acid is also associated
with a decrease in the fractional excretion of oxa-
late, whereas the acute administration of calcium
does not significantly affect oxalate transport.
Acknowledgments
A portion of this work appeared in abstract form
inAbstAm Soc Nephrol, 1978, p. l32A. Dr. Knight
is a Research Associate of the Veterans Administra-
tion. Dr. Taylor was a Fellow in Nephrology of Baylor
College of Medicine. Mr. H. Babino gave technical
assistance, and Ms. P. Dunham gave secretarial as-
sistance. Dr. H. Binder and Ms. D. Whitting (Yale
University School of Medicine, New Haven, Con-
necticut) performed the chemical determinations of
the oxalate concentrations in the urine. MK-196
576 Knight et at
was supplied by Dr. G. Fanelli, Jr., of the Merck
Institute.
Reprint requests to Dr. T. F. Knight, V.A. Medical Center,
2002 Holcombe Blvd., Houston, Texas 77211, USA
References
1. YENOT ER, GUAY GF, GARCIA DA: The use of thiazides in
the prevention of renal calculi. Can Med Assoc J 102:614—
620, 1970
2. COE FL, KAVALACH AG: Hypercalciuria and hyper-
uricosuria in patients with calcium nephrolithiasis. N EngI J
Med 291:1344-1350, 1974
3. LAMBERG BA, KUHLBACH B: Effect of chiorothiazide and
hydrochiorothiazideon the excretion of calcium in the urine.
Scand J Clin Lab Invest 2:351-357, 1959
4. COSTANZO LS, WEINER IM: On the hypocalciuric action of
hydrochiorothiazide. J Clin Invest 54:628-636, 1974
5. Sutu WN, HULL AR, RECTOR FC JR, SELDIN DW: Mecha-
nisms of the effects of thiazide diuretics on calcium and uric
acid (abst). J Clin Invest 46:1121, 1967
6. WEIN MAN EJ, STEPLOCK D, SuKI WN, EKNOYAN G: Urate
reabsorption in proximal convoluted tubule of the rat kid-
ney. Am J Physiol 231:509—515, 1976
7. DEMARTINI FE, WHEATON EA, HEALEY LA, LARAGH JH:
Effect of chiorothiazide on renal excretion of uric acid. Am J
Med 32:572-577, 1962
8. MCKENZIE R, KNIGHT TF, WEINMAN EJ: The effects of in-
danyloxyacetic acid (MK-196) on electrolyte excretion in the
rat kidney. Proc Soc Exp Biol Med 153:202—204, 1976
9. WEINMAN EJ, KNIGHT TF, MCKENZIE R, EKNOYAN G:
Dissociation of urate from sodium transport in the rat proxi-
mal tubule. Kidney mt 10:295-300, 1976
10. HODGKINSON A, WILLIAMS A: An improved colorimetric
procedure for urine oxalate. Clin Chim Acta 36:127—132,
1972
11. WEINMAN EJ, FRANKFURT SJ, INCE A, SANSOM S: Renal
tubular transport of organic acids: Studies with oxalate and
para-aminohippurate in the rat. J Clin Invest 6 1:801-806,
1978
12. KUNAU RT JR, WELLER DR, WEBB HL: Clarification of the
site of action of chlorothiazide in the rat nephron. J Clin In-
vest 56:401-407, 1975
13. KNIGHT TF, SENEKJIAN HO, WEINMAN EJ: The effects of
para-aminohippurate on the renal transport of oxalate. Kid-
ney Int 15:38-42, 1979
14. BURG M, STONER L, CARDINAL J, GREEN N: Furosemide
effect on isolated perfused tubules. Am J Physiol 225:119—
124, 1973
15. COHANIM M, YENDT ER: Reduction in urine oxalate excre-
tion during chronic thiazide therapy (abst). Clin Sci
24:685A, 1976
16. YENDT ER, COHANIM M: Prevention of calcium stones with
thiazides. Kidney Int 13:397-409, 1978
17. DE ROUGEMONT D, HENCHOZ M, ROCH-RAMEL F: Renal
urate excretion at various plasma concentrations in the rat.
A free-flow micropuncture study. Am J Physiol 23 1:387-
392, 1976
18. ROCH-RAMEL F, DIEZI-CHOMETY F, DE ROUGEMONT D,
TELLIER M, WIDMER .1, PETERS G: Renal excretion of uric
acid in the rat: A micropuncture and microperfusion study.
Am J Physiol 230:768-776, 1976
19. BINDER HJ: Intestinal oxalate absorption. Gastroenterology
67:441—446, 1974
20. MCINTOSH GH, BELLING GB: An isotopic study of oxalate
excretion in sheep. Aust J Exp Biol Med Sci 53:479—487,
1975
